View in EDS

Efficacy and safety profile of vortioxetine as an add-on molecule in obsessive-compulsive disorder: a randomized double-blinded placebo-controlled superiority trial - a study protocol.

Saved in:
Bibliographic Details
Title: Efficacy and safety profile of vortioxetine as an add-on molecule in obsessive-compulsive disorder: a randomized double-blinded placebo-controlled superiority trial - a study protocol.
Authors: Mandal S; Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), Kalyani, West Bengal, India. sucharita.psy@aiimskalyani.edu.in., Mukhopadhyay K; Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), Kalyani, West Bengal, India., Guin A; College of Nursing, Tutor, All India Institute of Medical Sciences (AIIMS), Kalyani, West Bengal, India., Sorkhel R; Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), Kalyani, West Bengal, India., Mitra P; Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), Kalyani, West Bengal, India., Ojha B; Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), Kalyani, West Bengal, India., Verma K; Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), Kalyani, West Bengal, India., Mukherjee S; Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), Kalyani, West Bengal, India.
Source: BMC psychiatry [BMC Psychiatry] 2025 Nov 24; Vol. 25 (1), pp. 1116. Date of Electronic Publication: 2025 Nov 24.
Publication Type: Journal Article; Clinical Trial Protocol
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968559 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-244X (Electronic) Linking ISSN: 1471244X NLM ISO Abbreviation: BMC Psychiatry Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1471-244X
DOI:10.1186/s12888-025-07374-2